Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 42 % of short-term debt in 2026; threshold 65 %.
-
Busy address KBO
12 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2026
PHARMACIE LAURENT DELCOURT from Anderlecht, company number BE0461036347, closed financial year 2026 with a result of € 874,653 after tax. For that financial year PHARMACIE LAURENT DELCOURT recorded a gross margin of € 870,107 and equity of € -41,601. Compared with financial year 2025, the result moved from € -85,195 to € 874,653. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 10, 2026.
€ -41,601
▲ € 874,653 vs 2025
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 874,653
▲ still € 85,195 loss in 2025
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2026. Retained profit grew to € -104,101.
Debts at end 2026
None
No bank loans on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | 2026 | Change 2025 → 2026 | |
|---|---|---|---|---|---|
| Gross margin | € 174,694 | € 17,074 | € -10,107 | € 870,107 | ▲ € 880,214 |
| Profit after taxes | € -202,051 | € -156,640 | € -85,195 | € 874,653 | ▲ € 959,848 |
| Equity | € -674,419 | € -831,059 | € -916,254 | € -41,601 | ▲ € 874,653 |
| Total debts | € 978,492 | € 968,215 | € 920,005 | € 72,228 | ▼ 92% |
| Cash | € 8,030 | - | - | - | |
| Land & buildings | € 24,789 | - | - | - | |
| Retained profit | € -736,919 | € -893,559 | € -978,754 | € -104,101 | ▲ € 874,653 |
| Bank debt | € 93,562 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 304,073 | € 137,156 | € 8,751 | € 30,628 | ▲ 250% |
| Employees (FTE) | - | 0.1 | - | - |
Key figures of PHARMACIE LAURENT DELCOURT, fiscal years 2023 to 2026, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2027) expected before 27 December 2027.
What happened to PHARMACIE LAURENT DELCOURT?
What happened at PHARMACIE LAURENT DELCOURT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2026: profit of € 874,653. Source: NBB ↗
- Geert REYNIERS stepped down as director. NBB
- Geert REYNIERS became a director. NBB
- New establishment in Saint-Hubert. KBO
- Start of the company according to the CBE. KBO
In short
From € 202,051 loss in 2023 to € 874,653 profit in 2026.
Paid € 155 in corporate taxes since 2023.
Best year ever: 2026, with € 874,653 profit.
A new publication or filing at PHARMACIE LAURENT DELCOURT? We notify you, reason included.
Follow PHARMACIE LAURENT DELCOURTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2026 annual accounts
Geert REYNIERS
Managing director
Also active at: MULTIPHARMA GROUP, APOTHEEK SMISHOEK, Apotheek Willebroek, Apoteek Jespers - Cuijpers, APOTHEEK BOGAERT, APOTEEK P. Sergeant, APOTHEEK VANDYCK, Farmannso +12 more
since 2025 · until 2026
Establishments
Establishment units
Physical locations of this company
Marie Curiesquare 30
1070 Anderlecht
Place du Marché 23 2
6870 Saint-Hubert
Active since 23 July 1997
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 12 companies are registered at this address.
All companies at this address →MULTIPHARMA GROUP same network
Office des sociétés coopératives de grossistes pharmaceutiques et de pharmacies - Vereniging van coöperatieve vennootschappen van farmaceutische groothandelaars en apotheken
Apoteek Jespers - Cuijpers same network
€ 113,239 gross margin · 2025
APOTEEK P. Sergeant same network
€ 10,336 gross margin · 2025
APOTHEEK VANDYCK same network
€ 1,703 gross margin · 2025
+7 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0461.036.347
- VAT number
- BE 0461.036.347
- Registered office
- Marie Curiesquare 30, 1070 Anderlecht
- Names & denominations
- PHARMACIE LAURENT DELCOURT
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 4 July 1997
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers